205 related articles for article (PubMed ID: 31069381)
1. Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas.
Patil CG; Walker DG; Miller DM; Butte P; Morrison B; Kittle DS; Hansen SJ; Nufer KL; Byrnes-Blake KA; Yamada M; Lin LL; Pham K; Perry J; Parrish-Novak J; Ishak L; Prow T; Black K; Mamelak AN
Neurosurgery; 2019 Oct; 85(4):E641-E649. PubMed ID: 31069381
[TBL] [Abstract][Full Text] [Related]
2. Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide.
Dintzis SM; Hansen S; Harrington KM; Tan LC; Miller DM; Ishak L; Parrish-Novak J; Kittle D; Perry J; Gombotz C; Fortney T; Porenta S; Hales L; Calhoun KE; Anderson BO; Javid SH; Byrd DR
Arch Pathol Lab Med; 2019 Sep; 143(9):1076-1083. PubMed ID: 30550350
[TBL] [Abstract][Full Text] [Related]
3. Unexpected Binding of Tozuleristide "Tumor Paint" to Cerebral Vascular Malformations: A Potentially Novel Application of Fluorescence-Guided Surgery.
Kobets AJ; Nauen D; Lee A; Cohen AR
Neurosurgery; 2021 Jul; 89(2):204-211. PubMed ID: 33826729
[TBL] [Abstract][Full Text] [Related]
4. Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent.
Parrish-Novak J; Byrnes-Blake K; Lalayeva N; Burleson S; Fidel J; Gilmore R; Gayheart-Walsten P; Bricker GA; Crumb WJ; Tarlo KS; Hansen S; Wiss V; Malta E; Dernell WS; Olson JM; Miller DM
Int J Toxicol; 2017; 36(2):104-112. PubMed ID: 28403743
[TBL] [Abstract][Full Text] [Related]
5. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.
Yamada M; Miller DM; Lowe M; Rowe C; Wood D; Soyer HP; Byrnes-Blake K; Parrish-Novak J; Ishak L; Olson JM; Brandt G; Griffin P; Spelman L; Prow TW
Contemp Clin Trials Commun; 2021 Sep; 23():100830. PubMed ID: 34401600
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors.
Butte PV; Mamelak A; Parrish-Novak J; Drazin D; Shweikeh F; Gangalum PR; Chesnokova A; Ljubimova JY; Black K
Neurosurg Focus; 2014 Feb; 36(2):E1. PubMed ID: 24484247
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas During Surgery.
Lee JY; Thawani JP; Pierce J; Zeh R; Martinez-Lage M; Chanin M; Venegas O; Nims S; Learned K; Keating J; Singhal S
Neurosurgery; 2016 Dec; 79(6):856-871. PubMed ID: 27741220
[TBL] [Abstract][Full Text] [Related]
9. A Phase 1 Dose-Escalation Study of Oral 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent High-Grade Glioma.
Cozzens JW; Lokaitis BC; Moore BE; Amin DV; Espinosa JA; MacGregor M; Michael AP; Jones BA
Neurosurgery; 2017 Jul; 81(1):46-55. PubMed ID: 28498936
[TBL] [Abstract][Full Text] [Related]
10. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
Folaron M; Strawbridge R; Samkoe KS; Filan C; Roberts DW; Davis SC
J Neurosurg; 2018 Sep; 131(3):724-734. PubMed ID: 30192200
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate.
Baik FM; Hansen S; Knoblaugh SE; Sahetya D; Mitchell RM; Xu C; Olson JM; Parrish-Novak J; Méndez E
JAMA Otolaryngol Head Neck Surg; 2016 Apr; 142(4):330-8. PubMed ID: 26892902
[TBL] [Abstract][Full Text] [Related]
13. Engineering microglia as intraoperative optical imaging agent vehicles potentially for fluorescence-guided surgery in gliomas.
Guo L; Zhang X; Wei R; Li G; Sun B; Zhang H; Liu D; Wang C; Feng M
Biomater Sci; 2020 Feb; 8(4):1117-1126. PubMed ID: 31724666
[TBL] [Abstract][Full Text] [Related]
14. Near-Infrared Imaging with Second-Window Indocyanine Green in Newly Diagnosed High-Grade Gliomas Predicts Gadolinium Enhancement on Postoperative Magnetic Resonance Imaging.
Cho SS; Salinas R; De Ravin E; Teng CW; Li C; Abdullah KG; Buch L; Hussain J; Ahmed F; Dorsey J; Mohan S; Brem S; Singhal S; Lee JYK
Mol Imaging Biol; 2020 Oct; 22(5):1427-1437. PubMed ID: 31712948
[TBL] [Abstract][Full Text] [Related]
15. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
16. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.
Palmieri G; Cofano F; Salvati LF; Monticelli M; Zeppa P; Perna GD; Melcarne A; Altieri R; La Rocca G; Sabatino G; Barbagallo GM; Tartara F; Zenga F; Garbossa D
Technol Cancer Res Treat; 2021; 20():15330338211021605. PubMed ID: 34212784
[TBL] [Abstract][Full Text] [Related]
18. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
Mamelak AN; Rosenfeld S; Bucholz R; Raubitschek A; Nabors LB; Fiveash JB; Shen S; Khazaeli MB; Colcher D; Liu A; Osman M; Guthrie B; Schade-Bijur S; Hablitz DM; Alvarez VL; Gonda MA
J Clin Oncol; 2006 Aug; 24(22):3644-50. PubMed ID: 16877732
[TBL] [Abstract][Full Text] [Related]
19. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
[No Abstract] [Full Text] [Related]
20. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
Li L; Du Y; Chen X; Tian J
Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
